Raf Sciot
- Gastroenterology top 0.02%
- Gastrointestinal Tumor Research and Treatment 80
- Pulmonary and Respiratory Medicine top 0.02%
- Sarcoma Diagnosis and Treatment 229
- Rheumatology top 0.05%
- Bone Tumor Diagnosis and Treatments 63
- Soft tissue tumor case studies 62
- Neurology top 0.2%
- Neurofibromatosis and Schwannoma Cases 45
- Oncology top 0.2%
- Vascular Tumors and Angiosarcomas 50
-
- Cardiac tumors and thrombi 51
-
- Tumors and Oncological Cases 41
- Co-authors
- Maria Dêbiec‐RychterPaola Dal CinValeer DesmetPeter Van EykenHerman Van den BergheM. van GlabbekeFredrik MertensIvo De Wever
- Journals
- Genes Chromosomes and Cancer (30 papers)Histopathology (26 papers)Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin (18 papers)
- Partner nations
- BelgiumUnited StatesNetherlands
In The Last Decade
Raf Sciot
545 papers receiving 24.1k citations
Hit Papers
Peers
Comparison fields: 5 of 158
- Gastroenterology 5.0k
- Pulmonary and Respiratory Medicine 12.5k
- Rheumatology 5.7k
- Neurology 3.3k
- Oncology 5.2k
Countries citing papers authored by Raf Sciot
This map shows the geographic impact of Raf Sciot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raf Sciot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raf Sciot more than expected).
Fields of papers citing papers by Raf Sciot
This network shows the impact of papers produced by Raf Sciot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raf Sciot. The network helps show where Raf Sciot may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Raf Sciot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 8 | |
| 4 | 2017 | 16 | |
| 5 | 2017 | 65 | |
| 6 | 2016 | 29 | |
| 7 | 2014 | 121 | |
| 8 | 2014 | 42 | |
| 9 | 2012 | 59 | |
| 10 | 2011 | 41 | |
| 11 | 2011 | 102 | |
| 12 | 2011 | 37 | |
| 13 | 2010 | 68 | |
| 14 | 2009 | 92 | |
| 15 | 2009 | 49 | |
| 16 | Glomus tumors in neurofibromatosis type 1: genetic, functional, and clinical evidence of a novel association (vol 69, pg 7393, 2009) | 2009 | 4 |
| 17 | 2008 | 57 | |
| 18 | Cloning of the der(17)t(X;17)(p11;q25) alveolar soft part sarcoma identifies the ASPL-TFE3 gene fusion, a new molecular diagnostic marker | 2001 | 1 |
| 19 | 2000 | 157 | |
| 20 | 2000 | 9 |
About Raf Sciot
Raf Sciot is a scholar working on Gastroenterology, Rheumatology and Pulmonary and Respiratory Medicine, having authored 555 papers that have together received 24.8k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (229 papers), Gastrointestinal Tumor Research and Treatment (80 papers), Bone Tumor Diagnosis and Treatments (63 papers), Soft tissue tumor case studies (62 papers), Cardiac tumors and thrombi (51 papers), Vascular Tumors and Angiosarcomas (50 papers), Neurofibromatosis and Schwannoma Cases (45 papers) and Tumors and Oncological Cases (41 papers). The work is most often cited by research in Gastroenterology (5.0k citations), Pulmonary and Respiratory Medicine (12.5k citations) and Rheumatology (5.7k citations). Raf Sciot has collaborated with scholars based in Belgium, United States and Netherlands. Frequent co-authors include Maria Dêbiec‐Rychter, Paola Dal Cin, Valeer Desmet, Peter Van Eyken, Herman Van den Berghe, M. van Glabbeke, Fredrik Mertens, Ivo De Wever, Nils Mandahl and Jaap Verweij. Their work appears in journals such as Genes Chromosomes and Cancer, Histopathology, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin, Journal of Clinical Oncology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.